ARSLAN, B. Et Al. 2022. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10 , 1071-1077.

ARSLAN, B., PAÇACI ÇETİN, G., Turk, M., GÜLMEZ, İ., & YILMAZ, İ., (2022). Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10, 1071-1077.

ARSLAN, BAHAR Et Al. "Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?," INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10, 1071-1077, 2022

ARSLAN, BAHAR Et Al. "Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10, pp.1071-1077, 2022

ARSLAN, B. Et Al. (2022) . "Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10, pp.1071-1077.

@article{article, author={BAHAR ARSLAN Et Al. }, title={Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?}, journal={INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY}, year=2022, pages={1071-1077} }